Regeneron Pharmaceuticals, Inc.

TD PRIVATE CLIENT WEALTH LLC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/5/2026

Shares

169

Value ($000)

130

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/5/2026	130	0.0%	169	12/31/2025
2025 Q3	10/27/2025	87	0.0%	154	9/30/2025
2025 Q2	7/15/2025	57	0.0%	108	6/30/2025
2025 Q1	4/29/2025	81	0.0%	127	3/31/2025
2024 Q4	2/11/2025	122	0.0%	171	12/31/2024
2024 Q3	11/18/2024	164	0.0%	156	9/30/2024
2024 Q2	8/14/2024	157	0.0%	149	6/30/2024
2024 Q1	8/16/2024	151	0.0%	157	3/31/2024
2023 Q4	8/16/2024	120	0.0%	137	12/31/2023
2023 Q3	8/16/2024	109	0.0%	132	9/30/2023
2023 Q2	8/16/2024	98	0.0%	136	6/30/2023
2023 Q1	8/16/2024	120	0.0%	146	3/31/2023
2022 Q4	8/16/2024	102	0.0%	142	12/31/2022
2022 Q3	8/16/2024	103	0.0%	149	9/30/2022
2022 Q2	8/16/2024	69	0.0%	116	6/30/2022
2022 Q1	8/16/2024	110	0.0%	157	3/31/2022
2021 Q4	8/16/2024	85	0.0%	134	12/31/2021
2021 Q3	8/16/2024	58	0.0%	96	9/30/2021
2021 Q2	8/16/2024	158	0.0%	282	6/30/2021
2021 Q1	8/16/2024	118	0.0%	250	3/31/2021
2020 Q4	8/16/2024	81	0.0%	167	12/31/2020
2020 Q3	8/16/2024	115	0.0%	206	9/30/2020
2020 Q2	8/16/2024	144	0.0%	231	6/30/2020
2020 Q1	8/16/2024	122	0.0%	249	3/31/2020
2019 Q4	8/16/2024	38	0.0%	100	12/31/2019